Dear business partners,
We see ourselves as a reliable partner with the highest quality requirements for our products and services. This claim remains our essential credo. Due to the greatly increased administrative requirements for the market approval of medical devices – particularly as a result of the new MDR Regulation in the European Union, but also in other approval areas – we have decided, with regard to a future-oriented focus, to change our business segment strategy in gastroenterology as of January 2023 and to phase out related products in the field of human medicine.
We would like to inform you immediately about this development and explain further background information. The flood of regulations already mentioned above has resulted in an above-average utilization of our resources in all areas of the company. Therefore, a clear focus is necessary to continue meeting our high standards of quality, service, and customer satisfaction seamlessly in all product areas. Moreover, it’s the basis to be able to invest in the innovative development of new technologies at the same time.
What does this step mean for you in concrete terms? You can continue to purchase our gastroenterology product portfolio until December 31, 2022 – after which we will discontinue sales. We will maintain our repair service for another five years and offer it until December 31, 2027. Products for veterinary supply in gastroenterology remain unaffected and will be offered as usual.
We look forward to continuing our partnership with you.